Iron for Restless Leg Syndrome

Research suggests that iron deficiency plays a central and well-documented role in restless leg syndrome, with multiple reviews and observational studies consistently linking low iron stores — particularly low ferritin levels — to the onset and severity of RLS symptoms, and identifying brain iron deficiency as a likely driver of the dopamine dysfunction underlying the condition. Studies indicate that iron supplementation, including both oral and intravenous formulations, is recognized as a legitimate treatment approach in clinical guidelines, with particular attention paid to vulnerable populations such as pregnant individuals, children with neurodevelopmental conditions, and those with chronic kidney disease, where the iron-RLS connection appears especially pronounced. The body of evidence includes several reviews, a meta-analysis on RLS prevalence in rheumatic disease, and observational studies, though notably few large randomized controlled trials are represented here, and some findings are mixed — for instance, one study found that specific iron lab values did not reliably distinguish RLS patients from non-RLS patients among women with iron deficiency anemia, and one neutral study points to additional molecular factors such as the gene BTBD9 and manganese exposure that complicate a straightforward iron-only explanation. Overall, the research supports iron status assessment as a meaningful part of RLS evaluation, while acknowledging that the condition is multifactorial and that iron therapy is one component of a broader management picture rather than a universal solution.